Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Current Opinion in Virology
- Vol. 38, 63-69
Abstract
No abstract availableKeywords
Funding Information
- Horizon 2020
- Université Libre de Bruxelles
- Horizon 2020 Framework Programme
- Fonds De La Recherche Scientifique - FNRS
This publication has 58 references indexed in Scilit:
- Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replicationRetrovirology, 2013
- HIV-1 transcription and latency: an updateRetrovirology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Redefining the Viral Reservoirs that Prevent HIV-1 EradicationImmunity, 2012
- Towards an HIV cure: a global scientific strategyNature Reviews Immunology, 2012
- HIV-1 Antiretroviral Drug TherapyCold Spring Harbor Perspectives in Medicine, 2012
- The Control of HIV Transcription: Keeping RNA Polymerase II on TrackCell Host & Microbe, 2011
- HIV-1 Tat and Host AFF4 Recruit Two Transcription Elongation Factors into a Bifunctional Complex for Coordinated Activation of HIV-1 TranscriptionMolecular Cell, 2010
- HIV-1 Tat Assembles a Multifunctional Transcription Elongation Complex and Stably Associates with the 7SK snRNPMolecular Cell, 2010